ReviewJournal of thoracic disease2025
The transparency and public availability of asbestos exposure levels.
Review in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Automated Fluorescence Microscopy-Based Sensing System for Continuous Detection of Airborne Asbestos Fibers on a PMSensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Asbestos exposure continues to be a critical public health concern due to its established link with serious respiratory diseases and malignancies. Despite the attention that asbestos-related disease has received and the litigation that has existed, asbestos-related deaths have increased over time. Public reporting of asbestos levels is essential to inform at-risk populations and facilitate regulatory compliance. Laws and practices regarding measuring of asbestos levels and reporting of these levels vary widely. Each different country has different standards that are applied to reporting. In many countries, legislation that has been passed by governing bodies has affected the amount of asbestos use and the reporting standards. Other countries have depended on community organizations to spread awareness and public pressure regarding standards of reporting. This review summarizes current practices in asbestos monitoring and public reporting, examines the strengths and limitations of existing frameworks, and explores technological and policy innovations aimed at improving transparency and public awareness. Enhancing data accessibility and public engagement remains vital to reducing asbestos-related health risks worldwide. Creating a uniform policy as widely as possible regarding asbestos reporting will empower the public and aid in reducing harm from asbestos-related disease. Future efforts should focus on creating comprehensive reporting policies and facilitating the ease at which the public can access this data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.